Invention Publication
- Patent Title: 5-Membered Heteroaryl Carboxamide Compounds for Treatment of HBV
-
Application No.: US17989237Application Date: 2022-11-17
-
Publication No.: US20240150324A1Publication Date: 2024-05-09
- Inventor: Simon Nicolas HAYDAR , Leping LI , Mark G. BURES , Roopa RAI , Lynne BANNEN , Michael WALKER
- Applicant: Assembly Biosciences, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Assembly Biosciences, Inc.
- Current Assignee: Assembly Biosciences, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07D403/08
- IPC: C07D403/08 ; A61P31/20 ; C07D231/38 ; C07D401/08 ; C07D403/04 ; C07D403/10 ; C07D403/12 ; C07D405/04 ; C07D413/04 ; C07D413/08 ; C07D417/08
Abstract:
The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.
Public/Granted literature
- US12030869B2 5-membered heteroaryl carboxamide compounds for treatment of HBV Public/Granted day:2024-07-09
Information query
